Works matching DE "DRUG therapy"

Results: 5000

The Liver Disease-Related Hypoglycemia: An Overview of the Impact, Management Approaches, and Underlying Mechanisms.

Published in:

British Journal of Hospital Medicine (17508460), 2025, v. 86, n. 6, p. 1, doi. 10.12968/hmed.2025.0028

By:

Shen, Li-xiao;
Wu, Yin-gui;
Ke, Mu-dan

Publication type:

Article

Chronic Obstructive Pulmonary Disease (COPD): Developments in Pharmacological Treatments.

Published in:

Drugs, 2025, v. 85, n. 7, p. 911, doi. 10.1007/s40265-025-02188-8

By:

Singh, Dave;
Higham, Andrew;
Mathioudakis, Alexander G.;
Beech, Augusta

Publication type:

Article

Datopotamab Deruxtecan: First Approval.

Published in:

Drugs, 2025, v. 85, n. 7, p. 965, doi. 10.1007/s40265-025-02185-x

By:

Blair, Hannah A.

Publication type:

Article

Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard Dosing.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 7, p. 1071, doi. 10.1007/s40262-025-01528-x

By:

Vos, Cornelis F.;
Coenen, Marieke J. H.;
ter Hark, Sophie E.;
Schellekens, Arnt F. A.;
Aarnoutse, Rob E.;
Janzing, Joost G. E.;
ter Heine, Rob

Publication type:

Article

Endotoxemia after high cutoff hemodialysis for treatment of patient with multiple myeloma can be prevented by using ultrapure dialysate: A case report.

Published in:

Hemodialysis International, 2013, v. 17, n. 4, p. 618, doi. 10.1111/j.1542-4758.2012.00757.x

By:

Gong, Dehua;
Ji, Daxi;
Zhang, Kaiyue;
Huang, Xianghua;
Huang, Gaoyuan;
Xu, Bin;
Liu, Zhihong

Publication type:

Article

Impact of free light chain hemodialysis in myeloma cast nephropathy: A case-control study.

Published in:

Hemodialysis International, 2011, v. 15, n. 4, p. 538, doi. 10.1111/j.1542-4758.2011.00587.x

By:

PETERS, Nicolas O.;
LAURAIN, Emmanuelle;
CRIDLIG, Joëlle;
HULIN, Cyrille;
CAO-HUU, Thanh;
FRIMAT, Luc

Publication type:

Article

Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.

Published in:

Hemodialysis International, 2006, v. 10, n. 4, p. 394, doi. 10.1111/j.1542-4758.2006.00136.x

By:

Odar-Cederlöf, Ingegerd;
Bjellerup, Per;
Williams, Amy;
Blagg, Christopher R.;
Twardowski, Zbylut;
Ting, George;
Kjellstrand, Carl M.

Publication type:

Article

Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination.

Published in:

2013

By:

Litterman, Adam J.;
Dudek, Arkadiusz Z.;
Largaespada, David A.

Publication type:

Opinion

Effects of conventional therapeutic interventions on the number and function of regulatory T cells.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e27025-1, doi. 10.4161/onci.27025

By:

Roselli, Mario;
Cereda, Vittore;
di Bari, Maria Giovanna;
Formica, Vincenzo;
Spila, Antonella;
Jochems, Caroline;
Farsaci, Benedetto;
Donahue, Renee;
Gulley, James L.;
Schlom, Jeffrey;
Guadagni, Fiorella

Publication type:

Article

TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 4, p. e23849-1, doi. 10.4161/onci.23849

By:

Sakuishi, Kaori;
Ngiow, Shin Foong;
Sullivan, Jenna M.;
Teng, Michele W. L.;
Kuchroo, Vijay K.;
Smyth, Mark J.;
Anderson, Ana C.

Publication type:

Article

Role of dendritic cells in the regulation of antitumor immunity.

Published in:

OncoImmunology, 2013, v. 2, n. 4, p. e23973-1, doi. 10.4161/onci.23973

By:

Wathelet, Nathalie;
Moser, Muriel

Publication type:

Article

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate.

Published in:

OncoImmunology, 2013, v. 2, n. 2, p. e23079-1, doi. 10.4161/onci.23079

By:

Pautier, Patricia;
Locher, Clara;
Robert, Caroline;
Deroussent, Alain;
Flament, Caroline;
Le Cesne, Axel;
Rey, Annie;
Bahleda, Ratislav;
Ribrag, Vincent;
Soria, Jean-Charles;
Vassal, Gilles;
Eggermont, Alexander;
Zitvogel, Laurence;
Chaput, Nathalie;
Paci, Angelo

Publication type:

Article

Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR+ NK cell levels correlate with disease outcome.

Published in:

OncoImmunology, 2013, v. 2, n. 2, p. e23080-1, doi. 10.4161/onci.23080

By:

Chaput, Nathalie;
Flament, Caroline;
Locher, Clara;
Desbois, Mélanie;
Rey, Annie;
Rusakiewicz, Sylvie;
Poirier-Colame, Vichnou;
Pautier, Patricia;
Le Cesne, Axel;
Soria, Jean-Charles;
Paci, Angelo;
Rosenzwajg, Michelle;
Klatzmann, David;
Eggermont, Alexander;
Robert, Caroline;
Zitvogel, Laurence

Publication type:

Article

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients.

Published in:

OncoImmunology, 2013, v. 2, n. 2, p. e23288-1, doi. 10.4161/onci.23288

By:

Zeeberg Iversen, Trine;
Klinge Brimnes, Marie;
Nikolajsen, Kirsten;
Sick Andersen, Rikke;
Reker Hadrup, Sine;
Hald Andersen, Mads;
Bastholt, Lars;
Svane, Inge Marie

Publication type:

Article

Improving the outcome of adoptive cell transfer by targeting tumor escape.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22059-1, doi. 10.4161/onci.22059

By:

Kaluza, Karen M.;
Vile, Richard

Publication type:

Article

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22620-1, doi. 10.4161/onci.22620

By:

Armeanu-Ebinger, Sorin;
Hoh, Alexander;
Wenz, Julia;
Fuchs, Joerg

Publication type:

Article

Anticancer activity of cardiac glycosides At the frontier between cell-autonomous and immunological effects.

Published in:

OncoImmunology, 2012, v. 1, n. 9, p. 1, doi. 10.4161/onci.21684

By:

Kepp, Oliver;
Menger, Laurie;
Vacchelli, Erika;
Adjemian, Sandy;
Martins, Isabelle;
Yuting Ma;
Sukkurwala, Abdul Qader;
Michaud, Mickaël;
Galluzzi, Lorenzo;
Zitvogel, Laurence;
Kroemer, Guido

Publication type:

Article

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

Published in:

OncoImmunology, 2012, v. 1, n. 9, p. 1, doi. 10.4161/onci.21513

By:

Godet, Yann;
Dosset, Magalie;
Borg, Christophe;
Adotevi, Olivier

Publication type:

Article

The tailored chemotherapy based on RRM1 immunohistochemical expression in patients with advanced non-small cell lung cancer.

Published in:

Cancer Biomarkers, 2013, v. 13, n. 6, p. 433, doi. 10.3233/CBM-130381

By:

Nie, Xin;
Cheng, Gang;
Ai, Bin;
Zhang, Shuai

Publication type:

Article

Low dose chemotherapeutic drugs without overt cytotoxic effects decrease the secretion of VEGF by cultured human tumor cells: A tentative relationship between drug type and tumor cell type response.

Published in:

Cancer Biomarkers, 2013, v. 12, n. 3, p. 135, doi. 10.3233/CBM-130301

By:

Aktas, Sedef Hande;
Akbulut, Hakan;
Akgun, Nalan;
Icli, Fikri

Publication type:

Article

Clinical significance of suppressor of cytokines signalling-3 mRNA expression from patients with non-Hodgkin lymphoma under chemotherapy.

Published in:

Cancer Biomarkers, 2012, v. 11, n. 1, p. 41, doi. 10.3233/CBM-2012-0262

By:

Attia, Fadia M.;
Hassan, Amany M.;
El-Maraghy, Nermine N.;
Ibrahium, Gehan H.

Publication type:

Article

Autoantibodies as biomarkers for ovarian cancer.

Published in:

Cancer Biomarkers, 2011, v. 8, n. 4/5, p. 187

By:

Tainsky, Michael A.;
Lokshin, Anna;
Chatterjee, Madhumita

Publication type:

Article

Value of diffusion-weighted imaging for assessing site-specific response of advanced ovarian cancer to neoadjuvant chemotherapy: Correlation of apparent diffusion coefficients with epithelial and stromal densities on histology.

Published in:

Cancer Biomarkers, 2011, v. 7, n. 4/5, p. 201, doi. 10.3233/CBM-2010-0194

By:

Kyriazi, Stavroula;
Nye, Emma;
Stamp, Gordon;
Collins, David J.;
Kaye, Stan B.;
deSouza, Nandita M.

Publication type:

Article

Quantitative diffusion weighted MRI: A functional biomarker of nodal disease in Hodgkin lymphoma?

Published in:

Cancer Biomarkers, 2011, v. 7, n. 4/5, p. 249, doi. 10.3233/CBM-2010-0197

By:

Punwani, Shonit;
Prakash, Vineet;
Bainbridge, Alan;
Taylor, Stuart A.;
Bandula, Steven;
Olsen, Oystein E.;
Hain, Sharon F.;
Shankar, Ananth;
Daw, Stephen;
Humphries, Paul

Publication type:

Article

Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients.

Published in:

Cancer Biomarkers, 2009, v. 5, n. 4/5, p. 167, doi. 10.3233/CBM-2009-0101

By:

Formica, V.;
Massara, M. C.;
Portarena, I.;
Fiaschetti, V.;
Grenga, I.;
Blanco, G. Del Vecchio;
Sileri, P.;
Tosetto, L.;
Skoulidis, F.;
Pallone, F.;
Roselli, M.

Publication type:

Article

Chemotherapeutic implications in microsatellite unstable colorectal cancer.

Published in:

Cancer Biomarkers, 2006, v. 2, n. 1/2, p. 51, doi. 10.3233/CBM-2006-21-206

By:

Won-Seok Jo;
Carethers, John M.

Publication type:

Article

Sequential molecularly targeted drug therapy including axitinib for a patient with end-stage renal failure and metastatic renal cell carcinoma.

Published in:

2016

By:

Hayato NISHIDA;
Hiroki FUKUHARA;
Atsushi YAMAGISHI;
Toshihiko SAKURAI;
Tomohiro SHIBASAKI;
Hisashi KAWAZOE;
Tomoyuki KATO;
Yoshihiko TOMITA

Publication type:

Case Study

Does pharmacotherapy improve cardiovascular outcomes in hemodialysis patients?

Published in:

Hemodialysis International, 2015, v. 19, p. S40, doi. 10.1111/hdi.12352

By:

Mittal, Mayank;
Aggarwal, Kul;
Littrell, Rachel L.;
Agrawal, Harsh;
Alpert, Martin A.

Publication type:

Article

Sunitinib alone or in combination with chemotherapy for the treatment of advanced breast cancer: A systematic review and meta-analysis.

Published in:

Breast Disease, 2016, v. 36, n. 2/3, p. 91, doi. 10.3233/BD-160218

By:

Elgebaly, Ahmed;
Menshawy, Ahmed;
El Ashal, Gehad;
Osama, Omnya;
Ghanem, Esraa;
Omar, Ahmed;
Negida, Ahmed

Publication type:

Article

Current treatment options in triple negative breast cancer.

Published in:

Breast Disease, 2011, v. 32, n. 1/2, p. 99, doi. 10.3233/BD-2010-0314

By:

Eng-Wong, Jennifer;
Zujewski, Jo Anne;
Rodler, Eve;
Korde, Larissa;
Gralow, Julie

Publication type:

Article

Infiltrating Lobular Carcinoma of the Breast: Systemic Treatment.

Published in:

Breast Disease, 2009, v. 30, n. 1, p. 45, doi. 10.3233/BD-2009-0281

By:

Farese, Simone Anna;
Aebi, Stefan

Publication type:

Article

Gene Expression Signatures to Predict the Development of Metastasis in Breast Cancer.

Published in:

Breast Disease, 2007, v. 26, n. 1, p. 149, doi. 10.3233/BD-2007-26113

By:

Nuyten, Dimitry S.A.;
van de Vijver, Marc J.

Publication type:

Article

Late Effects of Breast Radiotherapy in Young Women.

Published in:

Breast Disease, 2005, v. 23, n. 1, p. 53

By:

Raj, Katelyn A.;
Marks, Lawrence B.;
Prosnitz, Robert G.

Publication type:

Article

Surgical Aspects of Inflammatory Breast Cancer.

Published in:

Breast Disease, 2005, v. 22, n. 1, p. 67

By:

Kell, Malcolm R.;
Morrow, Monica

Publication type:

Article

Inflammatory Breast Cancer: Current Concepts in Local Management.

Published in:

Breast Disease, 2005, v. 22, n. 1, p. 75

By:

Bristol, Ian J.;
Buchholz, Thomas A.

Publication type:

Article

Systemic Treatments for Inflammatory Breast Cancer.

Published in:

Breast Disease, 2005, v. 22, n. 1, p. 55

By:

Yang, Charles H.;
Cristofanilli, Massimo

Publication type:

Article

When Not to Treat – Chemotherapy for Small (≤ 1 cm) Breast Cancers.

Published in:

Breast Disease, 2004, v. 21, n. 1, p. 33, doi. 10.3233/BD-2004-21105

By:

Soule, Sharon E.

Publication type:

Article

Long-Term Complications of Adjuvant Chemotherapy for Early Stage Breast Cancer.

Published in:

Breast Disease, 2004, v. 21, n. 1, p. 55, doi. 10.3233/BD-2004-21108

By:

Partridge, Ann H.;
Winer, Eric P.

Publication type:

Article

Neoadjuvant Chemotherapy.

Published in:

Breast Disease, 2004, v. 21, n. 1, p. 23, doi. 10.3233/BD-2004-21104

By:

Green, Marjorie C.;
Esteva, Francisco J.;
Hortobagyi, Gabriel N.

Publication type:

Article

Management Recommendations for Adjuvant Systemic Breast Cancer Therapy.

Published in:

Breast Disease, 2004, v. 21, n. 1, p. 15, doi. 10.3233/BD-2004-21103

By:

Perez, Edith A.

Publication type:

Article

Impact of Radiotherapy and Chemotherapy on Planning and Outcome of Breast Reconstruction.

Published in:

Breast Disease, 2002, v. 16, n. 1, p. 37, doi. 10.3233/BD-2002-16107

By:

Agarwal, Tripti;
Hultman, C. Scott

Publication type:

Article

Selection Bias in Clinical Trials.

Published in:

Breast Disease, 2001, v. 14, n. 1, p. 31, doi. 10.3233/BD-2001-14105

By:

Miller, Kathy D.;
Rahman, Zia U.;
Sledge Jr., George W.

Publication type:

Article

Quality of Life Issues Among Women Undergoing High-Dose Chemotherapy for Breast Cancer.

Published in:

Breast Disease, 2001, v. 14, n. 1, p. 41, doi. 10.3233/BD-2001-14106

By:

Partridge, Anne H.;
Bunnell, Craig A.;
Winer, Eric P.

Publication type:

Article

Integration of Neoadjuvant Chemotherapy and Surgery in the Treatment of Patients with Breast Carcinoma.

Published in:

Breast Disease, 2001, v. 12, n. 1, p. 69, doi. 10.3233/BD-2001-12108

By:

Kuerer, Henry M.;
Singletary, S. Eva

Publication type:

Article

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

Published in:

OncoImmunology, 2012, v. 1, n. 4, p. 432, doi. 10.4161/onci.19545

By:

Manuel, Manuarii;
Trédan, Olivier;
Bachelot, Thomas;
Clapisson, Gilles;
Courtier, Anais;
Parmentier, Gilles;
Rabeony, Tioka;
Grives, Audrey;
Perez, Solène;
Mouret, Jean-François;
Perol, David;
Chabaud, Sylvie;
Ray-Coquard, Isabelle;
Labidi-Galy, Intidhar;
Heudel, Pierre;
Pierga, Jean-Yves;
Caux, Christophe;
Blay, Jean-Yves;
Pasqual, Nicolas;
Ménétrier-Caux, Christine

Publication type:

Article

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?

Published in:

OncoImmunology, 2012, v. 1, n. 2, p. 258, doi. 10.4161/onci.1.2.18343

By:

Sommariva, Michele;
De Cecco, Loris;
Tagliabue, Elda;
Balsari, Andrea

Publication type:

Article

STATing the importance of immune modulation by platinum chemotherapeutics.

Published in:

OncoImmunology, 2012, v. 1, n. 2, p. 234, doi. 10.4161/onci.1.2.18126

By:

Hato, Stanleyson V.;
de Vries, I. Jolanda M.;
Lesterhuis, W. Joost

Publication type:

Article

Trial watch: Chemotherapy with immunogenic cell death inducers.

Published in:

OncoImmunology, 2012, v. 1, n. 2, p. 179, doi. 10.4161/onci.1.2.19026

By:

Vacchelli, Erika;
Galluzzi, Lorenzo;
Fridman, Wolf Hervé;
Galon, Jerome;
Sautès-Fridman, Catherine;
Tartour, Eric;
Zitvogel, Laurence;
Kroemer, Guido

Publication type:

Article

Identifying Subtle Motor Deficits Before Parkinson's Disease is Diagnosed: What to Look for?

Published in:

Journal of Parkinson's Disease, 2024, v. 14, p. S287, doi. 10.3233/JPD-230350

By:

Maetzler, Walter;
Mirelman, Anat;
Pilotto, Andrea;
Bhidayasiri, Roongroj

Publication type:

Article

Physical Exercise as a Potential Treatment for Fatigue in Parkinson's Disease? A Systematic Review and Meta-Analysis of Pharmacological and Non-Pharmacological Interventions.

Published in:

Journal of Parkinson's Disease, 2023, v. 13, n. 5, p. 659, doi. 10.3233/JPD-225116

By:

Folkerts, Ann-Kristin;
Nielsen, Jörn;
Gollan, Romina;
Lansu, Annika;
Solfronk, Dominik;
Monsef, Ina;
Ernst, Moritz;
Skoetz, Nicole;
Zeuner, Kirsten E.;
Kalbe, Elke

Publication type:

Article